vs
Side-by-side financial comparison of DULUTH HOLDINGS INC. (DLTH) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
DULUTH HOLDINGS INC. is the larger business by last-quarter revenue ($114.9M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -9.6%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-8.9M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -31.6%).
Duluth Holdings Inc., which primarily sells goods through its Duluth Trading Company brand, is an American workwear and accessories company.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
DLTH vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $114.9M | $75.5M |
| Net Profit | $-10.1M | — |
| Gross Margin | 53.8% | 69.3% |
| Operating Margin | -7.7% | 22.7% |
| Net Margin | -8.8% | — |
| Revenue YoY | -9.6% | 27.7% |
| Net Profit YoY | 64.6% | — |
| EPS (diluted) | $-0.29 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $114.9M | $75.5M | ||
| Q3 25 | $131.7M | $54.5M | ||
| Q2 25 | $102.7M | $52.4M | ||
| Q1 25 | $241.3M | $46.0M | ||
| Q4 24 | $127.1M | $59.1M | ||
| Q3 24 | $141.6M | $80.5M | ||
| Q2 24 | $116.7M | $47.1M | ||
| Q1 24 | $245.6M | $43.8M |
| Q4 25 | $-10.1M | — | ||
| Q3 25 | $1.3M | $8.8M | ||
| Q2 25 | $-15.3M | $5.9M | ||
| Q1 25 | $-5.6M | $3.0M | ||
| Q4 24 | $-28.2M | — | ||
| Q3 24 | $-2.0M | $20.3M | ||
| Q2 24 | $-7.9M | $-4.5M | ||
| Q1 24 | $6.4M | $-4.8M |
| Q4 25 | 53.8% | 69.3% | ||
| Q3 25 | 54.7% | 77.7% | ||
| Q2 25 | 52.0% | 76.5% | ||
| Q1 25 | 44.1% | 77.1% | ||
| Q4 24 | 52.3% | 76.4% | ||
| Q3 24 | 52.3% | 63.9% | ||
| Q2 24 | 52.8% | 77.4% | ||
| Q1 24 | 48.2% | 75.5% |
| Q4 25 | -7.7% | 22.7% | ||
| Q3 25 | 1.8% | 17.6% | ||
| Q2 25 | -12.0% | 12.7% | ||
| Q1 25 | -1.8% | 8.7% | ||
| Q4 24 | -17.4% | 22.6% | ||
| Q3 24 | -1.1% | 27.4% | ||
| Q2 24 | -7.7% | -4.6% | ||
| Q1 24 | 3.6% | -5.3% |
| Q4 25 | -8.8% | — | ||
| Q3 25 | 1.0% | 16.2% | ||
| Q2 25 | -14.9% | 11.2% | ||
| Q1 25 | -2.3% | 6.5% | ||
| Q4 24 | -22.2% | — | ||
| Q3 24 | -1.4% | 25.2% | ||
| Q2 24 | -6.7% | -9.6% | ||
| Q1 24 | 2.6% | -11.0% |
| Q4 25 | $-0.29 | $0.26 | ||
| Q3 25 | $0.04 | $0.17 | ||
| Q2 25 | $-0.45 | $0.12 | ||
| Q1 25 | $-0.17 | $0.06 | ||
| Q4 24 | $-0.84 | $0.40 | ||
| Q3 24 | $-0.06 | $0.41 | ||
| Q2 24 | $-0.24 | $-0.09 | ||
| Q1 24 | $0.20 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.2M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $160.6M | $130.3M |
| Total Assets | $468.0M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $97.5M | ||
| Q3 25 | $5.7M | $94.4M | ||
| Q2 25 | $8.6M | $96.0M | ||
| Q1 25 | $3.3M | $93.2M | ||
| Q4 24 | $9.3M | $101.0M | ||
| Q3 24 | $9.8M | $96.7M | ||
| Q2 24 | $6.8M | $96.8M | ||
| Q1 24 | $32.2M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $160.6M | $130.3M | ||
| Q3 25 | $170.0M | $115.3M | ||
| Q2 25 | $167.9M | $104.7M | ||
| Q1 25 | $182.7M | $97.1M | ||
| Q4 24 | $188.1M | $92.1M | ||
| Q3 24 | $215.7M | $71.1M | ||
| Q2 24 | $218.4M | $48.5M | ||
| Q1 24 | $222.8M | $51.0M |
| Q4 25 | $468.0M | $216.3M | ||
| Q3 25 | $433.8M | $202.9M | ||
| Q2 25 | $463.7M | $194.9M | ||
| Q1 25 | $452.4M | $196.2M | ||
| Q4 24 | $533.1M | $213.3M | ||
| Q3 24 | $488.6M | $220.7M | ||
| Q2 24 | $471.4M | $205.0M | ||
| Q1 24 | $491.2M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.7M | $14.4M |
| Free Cash FlowOCF − Capex | $-8.9M | $14.4M |
| FCF MarginFCF / Revenue | -7.8% | 19.1% |
| Capex IntensityCapex / Revenue | 2.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.7M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.7M | $14.4M | ||
| Q3 25 | $32.0M | $9.7M | ||
| Q2 25 | $-56.5M | $14.1M | ||
| Q1 25 | $41.2M | $3.6M | ||
| Q4 24 | $-41.1M | $15.6M | ||
| Q3 24 | $16.6M | $11.0M | ||
| Q2 24 | $-33.7M | $1.0M | ||
| Q1 24 | $69.7M | $11.2M |
| Q4 25 | $-8.9M | $14.4M | ||
| Q3 25 | $29.8M | $9.7M | ||
| Q2 25 | $-57.8M | $14.1M | ||
| Q1 25 | $38.7M | $3.6M | ||
| Q4 24 | $-43.7M | $15.6M | ||
| Q3 24 | $15.0M | $11.0M | ||
| Q2 24 | $-35.2M | $1.0M | ||
| Q1 24 | $60.6M | — |
| Q4 25 | -7.8% | 19.1% | ||
| Q3 25 | 22.6% | 17.7% | ||
| Q2 25 | -56.3% | 26.8% | ||
| Q1 25 | 16.0% | 7.7% | ||
| Q4 24 | -34.4% | 26.4% | ||
| Q3 24 | 10.6% | 13.7% | ||
| Q2 24 | -30.2% | 2.1% | ||
| Q1 24 | 24.7% | — |
| Q4 25 | 2.0% | 0.0% | ||
| Q3 25 | 1.7% | 0.0% | ||
| Q2 25 | 1.3% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 2.1% | 0.0% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 1.3% | 0.0% | ||
| Q1 24 | 3.7% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 25.40× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.86× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLTH
| Sales Channel Directly To Consumer | $67.4M | 59% |
| Sales Channel Through Intermediary | $47.4M | 41% |
PBYI
Segment breakdown not available.
